Our Expert in France
No results available
LBO holding structure France decisions sit at the heart of every leveraged acquisition of a French target, and in 2026 the stakes are higher than ever. Sponsors, private equity funds, founders and in-house counsel must now weigh tax efficiency against tightening EU anti-abuse rules, a demanding French foreign investment screening regime, and the Anti-Tax Avoidance Directive (ATAD) interest limitation measures that apply across the European Union. This guide takes a clear position: there is no universally “best” jurisdiction, but there is a best choice for your specific deal facts, and we tell you how to identify it. We compare France, Luxembourg, the Netherlands and the United Kingdom side by side, then give you an unambiguous decision framework.
By the end, you will know which holding company to use, why, and what to lock in before signing.
France remains one of Europe’s deepest mid-cap LBO markets, supported by an active sponsor community and an established base of transactional counsel. When sponsors ask “who are the top private equity firms in France? ” or “who are the top lawyers in France? “, the practical answer is that the right advisor is the one whose experience matches your deal profile, cross-border financing, FDI clearance and multi-jurisdiction tax structuring. You can shortlist specialists through the GLE lawyer directory, France private equity lawyers and review wider transactional context in the Asset sale vs share sale, France 2026 guide.
A private equity lawyer, in short, is counsel who structures the acquisition vehicle, negotiates financing and the purchase agreement, and manages regulatory clearances through to exit.
This article is general information, not legal or tax advice. Rates and statutory positions change, verify current figures against the official sources cited before acting on any transaction.
The choice of an acquisition holding structure in France turns on a disciplined assessment of seven variables. Run every candidate jurisdiction through the same filter rather than defaulting to a favourite SPV domicile:
Score each jurisdiction honestly. A tax-efficient holding in France or abroad only works if substance and treaty access hold up under scrutiny. In 2026, the deciding factor is rarely the statutory rate, it is whether your structure survives anti-abuse challenge.
Four facts move the needle decisively. First, the jurisdiction and sector of the target: a French operating company in a sensitive sector invites FDI screening regardless of where the holdco sits. Second, the investor base: a French-dominated pool points onshore; an international pool rewards treaty routing. Third, the intended exit route: a trade sale to a foreign strategic buyer values a clean, treaty-covered holdco, while an IPO may favour a specific listing jurisdiction. Fourth, the financing mix: heavy acquisition debt makes interest deductibility and ATAD limits a primary driver. Map these before you model tax.
If you cannot commit to substance, do not assume a foreign SPV will deliver tax savings. That single discipline avoids most post-closing disputes.
The table below is the centrepiece of this guide. Treat it as a screening tool, then apply the worked examples and decision framework that follow. Where a numeric rate matters, verify it as of signing against the official source for that jurisdiction.
| Dimension | France (onshore holdco) | Luxembourg | Netherlands | United Kingdom |
|---|---|---|---|---|
| Corporate tax profile | Full French corporate tax rules apply; predictable but higher compliance; dividends and gains governed by the French tax code (Code général des impôts). | Historically attractive holding regime with flexible consolidation; now subject to intensified substance and anti-abuse scrutiny. | Historically holding-friendly with an established rulings practice; substance requirements actively enforced. | Established holding regime; post-Brexit treaty positions vary; still efficient for certain exits. |
| Participation exemption / CGT on subsidiaries | Applies subject to shareholding and holding-period conditions; repatriation to individuals needs care. | Strong participation exemption, subject to substance and anti-abuse tests. | Favourable participation exemption, including on capital gains, subject to conditions. | Substantial shareholding exemption available; check post-Brexit treaty impacts. |
| Withholding on dividends / interest | Domestic withholding on outbound flows; treaties or applicable EU regimes may reduce or eliminate. | Treaty benefits available, but substance and anti-abuse can limit access. | Wide treaty network; efficient where genuine substance exists. | Extensive treaty network; post-Brexit considerations for EU flows. |
| Interest deductibility / thin cap | French interest limitation (ATAD-derived) plus transfer pricing; recent Finance Acts may tighten. | Deductibility subject to Luxembourg rules and ATAD. | Flexible intercompany rules, but ATAD applies. | Specific UK corporate interest restriction and BEPS-related rules. |
| Substance & compliance | High expectations where treaty benefits are claimed; local presence often needed. | High post-BEPS substance requirements; meaningful administrative burden. | Well-developed substance regime; authorities expect real management. | Substance required for treaty relief; HMRC scrutiny of conduits. |
| FDI / regulatory risk & timing | French FDI screening can delay or condition deals in critical sectors. | Less likely to trigger French FDI itself, but the French target remains reviewable. | Similar, holdco location does not exempt French operations from review. | UK parent does not avoid French screening for sensitive sectors; investor nationality matters. |
| Setup & running cost | Medium, onshore governance; payroll if substance needed. | Medium to high where real substance is implemented. | Medium, higher initial planning, efficient once established. | Medium, comparable to France; factor substance costs. |
| Exit / repatriation | Efficient for French investors; more complex for foreign investors due to domestic tax. | Often efficient for cross-border exits where substance and treaty hold. | Efficient, tax-neutral repatriation if properly structured. | Efficient for exits; treaty use needs careful post-Brexit review. |
| Practical fit for mid-cap LBOs | Lower foreign-law complexity; watch FDI and management incentive charges. | Strong for international sponsor pools, but substance is mandatory. | Attractive where ruling certainty and BV structures are used. | Good for a UK investor base; check treaty profile and domicile. |

Assume an international sponsor acquiring a French mid-cap target through a Luxembourg holding company, funded partly with shareholder and acquisition debt. Treaty relief can reduce withholding on upstream dividends and interest, and the participation exemption can shelter gains on a later sale of the French subsidiary. But those outcomes depend on genuine substance in Luxembourg, a resident board, an office, decision-making capacity and economic activity. Strip the substance away and the French tax authorities, backed by ATAD and the principal purpose test, can deny benefits. The after-tax IRR advantage is real only if the structure is defensible.
Now assume a predominantly France-based investor pool using a French holding company. Repatriation to French investors is simpler, there is no cross-border treaty routing to defend, and FDI engagement is handled onshore. The trade-off is full exposure to French corporate tax rules, domestic interest limitation and, on exit to foreign buyers, potentially higher friction. For a mid-cap LBO with French sponsors and management, the onshore route frequently wins on certainty and cost even where a foreign SPV looks marginally cheaper on paper.
The common thread across both examples is decisive for 2026: a low-substance foreign holding company will not unlock savings. Substance and treaty access, not headline rates, determine the result.
The economics of any LBO holding structure France analysis live in three cash flows: dividends up the chain, interest on acquisition and shareholder debt, and the capital gain on exit. Each interacts with domestic rules, EU directives and the relevant treaty network. Model all three together, optimising one can degrade another.
Dividends paid out of a French operating company to its holdco attract domestic withholding unless reduced or eliminated by treaty or an applicable EU regime (such as the Parent-Subsidiary Directive where its conditions are met). For a French holdco, intra-group distributions follow the French tax code, with the participation exemption (the “régime mère-fille”) capable of substantially reducing tax on qualifying dividends where the shareholding and holding-period conditions are met. For a foreign holdco in Luxembourg, the Netherlands or the UK, treaty relief can lower French withholding, but access is conditional on substance and on surviving anti-abuse tests. The OECD principal purpose test and ATAD-derived general anti-abuse rules allow authorities to look through arrangements whose main purpose is treaty shopping.
Document the commercial rationale and the genuine functions performed at holdco level from day one.
Interest deductibility is often the single largest tax lever in a leveraged deal, and it is also the most constrained. ATAD’s interest limitation rule caps net deductible borrowing costs across EU member states, and France applies interest limitation measures that successive Finance Acts can tighten. Shareholder loans and intercompany financing must also respect transfer pricing, rates and terms have to be arm’s length and documented. The UK operates its own corporate interest restriction and BEPS-related anti-avoidance rules. The practical consequence is that highly leveraged structures cannot assume full deductibility: run the limitation calculation for each candidate jurisdiction, because the location of the borrowing entity changes the available deduction.
Over-gearing a holdco in reliance on deductions that ATAD will cap is a recurring, avoidable error.
On exit, the capital gain on the sale of the operating company is where jurisdiction choice pays off, or fails to. France’s participation exemption can shelter much of a qualifying long-term gain subject to conditions (with a portion typically remaining taxable as a share of costs and expenses), but repatriation to individual French investors brings its own layer of tax. Luxembourg and the Netherlands offer strong participation exemptions on qualifying gains, conditional on substance and anti-abuse compliance, while the UK’s substantial shareholding exemption can achieve a similar result subject to its own tests and treaty position.
The decisive question is not whether an exemption exists on paper but whether your holdco qualifies and can defend that qualification at the moment of sale.
Substance is the pivot on which every cross-border LBO structure now turns. Post-BEPS and under ATAD, tax authorities across the EU and the UK expect a holding company claiming treaty or directive benefits to be more than a nameplate. In 2026, taxpayers must be able to evidence the commercial reality of their structures.
Substance is tested by function, not form. Expect authorities to look for a genuine local office, qualified people with decision-making authority, board meetings actually held and minuted in the jurisdiction, local bank accounts operated locally, and real economic activity commensurate with the holdco’s role. A company whose only activity is to hold shares and sign documents prepared elsewhere is vulnerable. Luxembourg has tightened its substance expectations materially since BEPS, and the Netherlands applies a well-developed regime in which courts and the tax authority expect real management. Plan substance into the acquisition vehicle’s operating budget, it is a cost of obtaining the benefit, not an optional extra.
Each jurisdiction imposes its own filing, accounting and, in many cases, audit obligations. A substance-bearing Luxembourg or Netherlands holdco carries recurring costs for office, staff, directors, accounting and audit. France’s onshore compliance is predictable but not light. Budget these running costs over the full hold period, not just at setup, they erode the modelled tax advantage if ignored.
Create and retain a contemporaneous substance file: board minutes showing genuine deliberation in the jurisdiction, evidence of local management, employment contracts, office lease, bank mandates and a written commercial rationale for the structure. Keep transfer pricing documentation for all intercompany financing. Where the relevant authority offers advance certainty (for example a tax ruling), consider obtaining it. Good documentation, built from completion, is the single best defence against a denial-of-benefits challenge on exit.
Tax is only half the picture. Regulatory clearances can delay or condition an LBO regardless of where the holding company sits, and French foreign investment screening is the one most sponsors underestimate.
France screens foreign direct investment in sensitive and strategic sectors under the regime set out in the Monetary and Financial Code and its implementing decrees, within a framework shaped by the EU FDI screening regulation. Where a target operates in a protected sector, acquisition by a foreign investor can require prior authorisation from the Minister of the Economy (handled through the Treasury directorate), and approval may be conditioned or, in rare cases, refused. Crucially, locating the holdco in Luxembourg, the Netherlands or the UK does not of itself exempt the French target’s business from review, the analysis follows the ultimate investor’s characteristics and the target’s activities, not merely the holdco’s address.
Note that the rules distinguish between investors from outside the EU/EEA and intra-EU/EEA investors. Clearance can add weeks or months to a timetable.
Treat regulatory timing as a structuring input, not an afterthought, it affects price certainty, financing and deal risk allocation.
This is the recommendation. Pick the jurisdiction that matches your deal facts, then commit fully to the substance and compliance it requires.
The right LBO holding structure France decision is the one that balances after-tax return, defensible substance, regulatory certainty and running cost for your specific transaction, not the one with the lowest headline rate. France rewards onshore simplicity for domestic deals; Luxembourg and the Netherlands reward international sponsors who commit to real substance; the UK suits a UK-centric base alive to post-Brexit treaty effects. Whichever you choose, substance and treaty access will decide the outcome in 2026. Take these next steps:
For related depth, see the planned guides on PE exit tax planning in France, financing the holdco and intercompany loans, and when to use Luxembourg or Netherlands SPVs for French LBOs.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Yam Atallah at Franklin Societe D’avocats, a member of the Global Law Experts network.
posted 3 minutes ago
posted 25 minutes ago
posted 47 minutes ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
posted 3 hours ago
No results available
Find the right Legal Expert for your business
Send welcome message